Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
Open Access
- 28 December 2011
- journal article
- Published by Springer Science and Business Media LLC in Cardiovascular Diabetology
- Vol. 10 (1), 117
- https://doi.org/10.1186/1475-2840-10-117
Abstract
Type 2 diabetes mellitus (T2DM) is associated with an increased risk of atherosclerotic vascular disease, but it is unknown whether the other way around is true too. C57BL/6 (B6) and BALB/cJ (BALB) are two mouse strains that differ markedly in their susceptibility to atherosclerosis. In this study we investigated the development of diet-induced T2DM in these two strains. When deficient in apolipoprotein E (apoE-/-) and fed a Western diet for 12 weeks, atherosclerosis-susceptible B6 mice developed significant hyperglycemia. In contrast, atherosclerosis-resistant BALB apoE-/- mice had much lower plasma glucose levels than B6.apoE-/- mice on either chow or Western diet and during an intraperitoneal glucose tolerance test. In response to glucose BALB.apoE-/- mice displayed both the first and second phases of insulin secretion but the second phase of insulin secretion was absent in B6.apoE-/- mice. In response to insulin B6.apoE-/- mice showed a deeper and longer-lasting fall in blood glucose levels while BALB.apoE-/- mice showed little reduction in glucose levels. Pancreatic islet area of BALB.apoE-/- mice on light microscopy nearly doubled the area of B6.apoE-/- mice. Most circulating proinflammatory cytokines were lower in BALB.apoE-/- than in B6.apoE-/- mice on the Western diet, as determined by protein arrays. Increased macrophage infiltration in islets was observed in B6.apoE-/- mice by immunostaining for Mac2 and also by flow cytometry. This study demonstrates that defects in insulin secretion rather than defects in insulin resistance explain the marketed difference in susceptibility to T2DM in the B6.apoE-/- and BALB.apoE-/- mouse model. A smaller islet mass and more prominent islet inflammation may explain the vulnerability of B6.apoE-/- mice to diet-induced diabetes.Keywords
This publication has 44 references indexed in Scilit:
- Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only miceCardiovascular Diabetology, 2011
- The genetics of type 2 diabetes: what have we learned from GWAS?Annals of the New York Academy of Sciences, 2010
- Wound Healing in Mice with High-Fat Diet- orobGene-Induced Diabetes-Obesity Syndromes: A Comparative StudyExperimental Diabetes Research, 2010
- Quantitative Trait Locus Analysis of Neointimal Formation in an Intercross Between C57BL/6 and C3H/HeJ Apolipoprotein E–Deficient MiceCirculation: Cardiovascular Genetics, 2009
- Phylometabonomic Patterns of Adaptation to High Fat Diet Feeding in Inbred MicePLOS ONE, 2008
- Nonobese Diabetic (NOD) Mice Congenic for a Targeted Deletion of 12/15-Lipoxygenase Are Protected From Autoimmune DiabetesDiabetes, 2008
- Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibilityBiochemical and Biophysical Research Communications, 2005
- Apo A-I inhibits foam cell formation in apo E–deficient mice after monocyte adherence to endotheliumJCI Insight, 1999
- Defective Glucose-Stimulated Insulin Release from Perifused Islets of C57BL/6J MicePancreas, 1995
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992